Musculoskeletal Pain

Latest

ACR Updates COVID-19 Vaccine Guidance for Managing Patients With Rheumatic and Musculoskeletal Diseases

By

Meghna Rao

The American College of Rheumatology updated COVID-19 vaccine clinical guidance to include recommendations regarding medication timing considerations during the management of patients with rheumatic and musculoskeletal diseases.

Pfizer and Moderna Vaccines Effective Against New NYC Variant​

The Pfizer-BioNTech and Moderna COVID-19 vaccines protect against serious illness and death from the coronavirus variant first identified in New York City.

Severe Maternal Morbidity Increased With COVID-19 in Pregnancy

COVID-19 in pregnancy is associated with increased severe maternal morbidity and mortality.

European Union Will Allow Fully Vaccinated US Tourists This Summer

American tourists who are fully vaccinated against COVID-19 will be allowed to visit the European Union over the summer.

CDC Reports Millions of Americans Have Missed Second COVID-19 Vaccine Dose

More than 5 million Americans have missed the second dose of their COVID-19 vaccine.

COVID-19 Death Rates and Risk Perception Led to More Time Spent At Home

By

Bradley van Paridon

Investigators collected survey data on demographics, risk perception, and death rate to assess their impact on voluntary behaviors, such as time spent at home.

Fake Pfizer COVID-19 Vaccines Being Sold Online

Counterfeit versions of the Pfizer COVID-19 vaccine are being sold online, the company warns.

Guidance Updated for Assessing Allergy Risk of COVID-19 Vaccines

An updated pre-COVID-19 vaccine risk stratification algorithm is presented for use in patients with reported allergic reactions.

CDC Panel Recommends Resuming Use of Janssen COVID-19 Vaccine

The United States should resume administering the Johnson & Johnson COVID-19 vaccine, the Centers for Disease Control and Prevention voted on Friday.

Rare Adverse Thrombotic Events After ChAdOx1 nCov-19 Vaccination

By

Rita Aghjayan

To better understand the development of a rare clotting, investigators conducted a PF4-heparin ELISA and a PF4 ELISA to identify platelet-activating antibodies.